Pure Global

“Abbott” XIENCE Alpine Everolimus Eluting Coronary Stent System - Taiwan Registration 1c6e5191336a83e044de4ec8ec778ff2

Access comprehensive regulatory information for “Abbott” XIENCE Alpine Everolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 1c6e5191336a83e044de4ec8ec778ff2 and manufactured by ABBOTT VASCULAR. The authorized representative in Taiwan is Abbott Medical Taiwan Co..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1c6e5191336a83e044de4ec8ec778ff2
Registration Details
Taiwan FDA Registration: 1c6e5191336a83e044de4ec8ec778ff2
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Abbott” XIENCE Alpine Everolimus Eluting Coronary Stent System
TW: “亞培”賽恩斯高艾諾莉茉斯冠狀動脈塗藥支架系統
Risk Class 3
MD

Registration Details

1c6e5191336a83e044de4ec8ec778ff2

Ministry of Health Medical Device Import No. 028278

DHA05602827801

Company Information

Ireland

Product Details

For details, it is Chinese approved copy of the imitation order

E Cardiovascular devices

E0001 Cardiovascular stents

Imported from abroad

Dates and Status

Mar 31, 2016

Mar 31, 2026